Metformin works by improving insulin resistance, decreasing the hepatic production of glucose by inhibiting gluconeogenesis and by an action on glucose-6-phosphatase, decreasing glycaemic values and also enhancing the effect of insulin on muscular glucose absorption. The gene discussed is INS; the disease is Insulin resistance.